Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 73

1.

[Prognostic effect of cytoplasmic CD79a expression in acute myeloid leukemia with t(8;21)].

Chung HJ, Chi HS, Cho YU, Lee EH, Jang S, Park CJ, Seo EJ.

Korean J Lab Med. 2007 Dec;27(6):388-93. Korean.

2.

CytCD79a expression in acute leukemia with t(8;21): biphenotypic or myeloid leukemia?

He G, Wu D, Sun A, Xue Y, Jin Z, Qiu H, Miao M, Tang X, Fu Z, Chen Z.

Cancer Genet Cytogenet. 2007 Apr 1;174(1):76-7. No abstract available.

PMID:
17350472
3.
4.

B cell-restricted human mb-1 gene: expression, function, and lineage infidelity.

Herren B, Burrows PD.

Immunol Res. 2002;26(1-3):35-43. Review.

PMID:
12403343
5.

Structure, chromosomal localization, and methylation pattern of the human mb-1 gene.

Ha H, Barnoski BL, Sun L, Emanuel BS, Burrows PD.

J Immunol. 1994 Jun 15;152(12):5749-57.

PMID:
8207205
6.
7.

The B-cell antigen receptor of the five immunoglobulin classes.

Venkitaraman AR, Williams GT, Dariavach P, Neuberger MS.

Nature. 1991 Aug 29;352(6338):777-81.

PMID:
1881434
8.
9.

Molecular cloning and expression pattern of a human gene homologous to the murine mb-1 gene.

Ha HJ, Kubagawa H, Burrows PD.

J Immunol. 1992 Mar 1;148(5):1526-31.

PMID:
1538135
10.

Structure and expression of the mb-1 transcript in human lymphoid cells.

Leduc I, Preud'homme JL, Cogné M.

Clin Exp Immunol. 1992 Oct;90(1):141-6.

11.

Tyrosine phosphorylation within the intrinsically disordered cytosolic domains of the B-cell receptor: an NMR-based structural analysis.

Rosenlöw J, Isaksson L, Mayzel M, Lengqvist J, Orekhov VY.

PLoS One. 2014 Apr 25;9(4):e96199. doi: 10.1371/journal.pone.0096199. eCollection 2014.

12.

Expression of the B-cell receptor component CD79a on immature myeloid cells contributes to their tumor promoting effects.

Luger D, Yang YA, Raviv A, Weinberg D, Banerjee S, Lee MJ, Trepel J, Yang L, Wakefield LM.

PLoS One. 2013 Oct 16;8(10):e76115. doi: 10.1371/journal.pone.0076115. eCollection 2013.

13.

Protein kinase C inhibitor sotrastaurin selectively inhibits the growth of CD79 mutant diffuse large B-cell lymphomas.

Naylor TL, Tang H, Ratsch BA, Enns A, Loo A, Chen L, Lenz P, Waters NJ, Schuler W, Dörken B, Yao YM, Warmuth M, Lenz G, Stegmeier F.

Cancer Res. 2011 Apr 1;71(7):2643-53. doi: 10.1158/0008-5472.CAN-10-2525. Epub 2011 Feb 15.

14.

Antibody-drug conjugates targeted to CD79 for the treatment of non-Hodgkin lymphoma.

Polson AG, Yu SF, Elkins K, Zheng B, Clark S, Ingle GS, Slaga DS, Giere L, Du C, Tan C, Hongo JA, Gogineni A, Cole MJ, Vandlen R, Stephan JP, Young J, Chang W, Scales SJ, Ross S, Eaton D, Ebens A.

Blood. 2007 Jul 15;110(2):616-23. Epub 2007 Mar 20.

15.

Lower levels of surface B-cell-receptor expression in chronic lymphocytic leukemia are associated with glycosylation and folding defects of the mu and CD79a chains.

Vuillier F, Dumas G, Magnac C, Prevost MC, Lalanne AI, Oppezzo P, Melanitou E, Dighiero G, Payelle-Brogard B.

Blood. 2005 Apr 1;105(7):2933-40. Epub 2004 Dec 9.

16.

PAX5 expression in acute leukemias: higher B-lineage specificity than CD79a and selective association with t(8;21)-acute myelogenous leukemia.

Tiacci E, Pileri S, Orleth A, Pacini R, Tabarrini A, Frenguelli F, Liso A, Diverio D, Lo-Coco F, Falini B.

Cancer Res. 2004 Oct 15;64(20):7399-404.

17.

Somatic hypermutation of the B cell receptor genes B29 (Igbeta, CD79b) and mb1 (Igalpha, CD79a).

Gordon MS, Kanegai CM, Doerr JR, Wall R.

Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4126-31. Epub 2003 Mar 21.

18.
19.

Domain deletions in the human polymeric Ig receptor disclose differences between its dimeric IgA and pentameric IgM interaction.

Norderhaug IN, Johansen FE, Krajci P, Brandtzaeg P.

Eur J Immunol. 1999 Oct;29(10):3401-9.

Supplemental Content

Support Center